Abstract
CO29 Real-World Benefit of Ataluren Treatment in Milestones Not Related to Ambulatory Function in Nonsense Duchenne Muscular Dystrophy Versus Standard of Care
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have